SCHEMBL811183

SCHEMBL811183

COS(=O)(=O)c1cc(Br)ccc1-c1ccc(Br)cc1S(=O)(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 1/20 0.43
TSHR P16473 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 3/20 0.41
PTPRC P08575 1/20 0.38
ALDH1A1 P00352 2/20 0.38
BCL2 P10415 1/20 0.37
MCL1 Q07820 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
ALPL P05186 1/20 0.35
WDR5 P61964 1/20 0.35
NPC1 O15118 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15352355 0.82 APLNR (0.42) TSHRSMN1; SMN2GLAGAAALDH1A1
SCHEMBL811253 0.81 TSHR (0.44) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL196544 0.79 S100A4 (0.39) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL15352707 0.77 NMT1 (0.46) TSHRSMN1; SMN2GLAGAAALDH1A1
SCHEMBL196909 0.77 TSHR (0.38) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL198020 0.77 TSHR (0.41) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL811473 0.76 TRPV4 (0.46) S100A4TSHRGAAALDH1A1MCL1
SCHEMBL197303 0.75 TSHR (0.37) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL197357 0.74 TSHR (0.39) S100A4TSHRSMN1; SMN2GLAGAA
SCHEMBL16583377 0.73 CA1 (0.50) SMN1; SMN2ALDH1A1WDR5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2390241-B1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2014-10-01 EP disclosed
US-8598349-B2 Method for manufacturing conjugated aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-12-03 US disclosed
US-8236920-B2 Polyarylene and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-07 US disclosed
EP-1995265-B1 POLYARYLENE AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL CO (JP) 2012-08-01 EP disclosed
EP-2390241-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2011-11-30 EP disclosed
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2011-11-10 US disclosed
US-20110256790-A1 THERMAL INSULATION CONTAINING SUPPLEMENTAL INFRARED RADIATION ABSORBING MATERIAL SAINT-GOBAIN ISOVER (FR) 2011-10-20 US disclosed
US-20100292481-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2010-11-18 US disclosed
EP-2233459-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-09-29 EP disclosed
US-20090326188-A1 Method for producing polyarylene SUMITOMO CHEMICAL COMPANY, LIMITED 2009-12-31 US disclosed
EP-2065420-A1 METHOD FOR PRODUCING POLYARYLENE Sumitomo Chemical Company, Limited (JP) 2009-06-03 EP disclosed
US-20090036632-A1 Polyarylene and Process for Producing the Same SUMITOMO CHEMICAL COMPANY, LIMITED 2009-02-05 US disclosed
EP-1995265-A1 POLYARYLENE AND PROCESS FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND C9, H1-10, CYP1A1 S100A4 4639/4885TSHR 185/4885SMN1; SMN2 2997/4885
US-20090036632-A1 Polyarylene and Process for Producing the Same CYP1A1, CYP1B1, C1R S100A4 4787/4885TSHR 69/4885SMN1; SMN2 4293/4885
US-20100292481-A1 METHOD FOR PRODUCING CONJUGATED AROMATIC COMPOUND TYR, PAH, AHR S100A4 2216/4885TSHR 2878/4885SMN1; SMN2 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.